Schrödinger Inc. (SDGR)
NASDAQ: SDGR
· Real-Time Price · USD
20.61
1.18 (6.07%)
At close: Oct 15, 2025, 3:59 PM
20.73
0.58%
After-hours: Oct 15, 2025, 07:52 PM EDT
Schrödinger Revenue by Type
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Software Products and Services | 200.94M | 195.8M | 180.4M | 169.4M | 166.42M | 160.37M | 159.17M | Upgrade | Upgrade | Upgrade | Upgrade |
| Software Products and Services Growth | +2.63% | +8.54% | +6.49% | +1.79% | +3.77% | +0.76% | +15.12% | Upgrade | Upgrade | Upgrade | - |
| Drug Discovery | 37.06M | 34.77M | 27.22M | 24.02M | 34.28M | 28.18M | 57.57M | Upgrade | Upgrade | Upgrade | Upgrade |
| Drug Discovery Growth | +6.57% | +27.75% | +13.32% | -29.93% | +21.62% | -51.04% | -5.73% | Upgrade | Upgrade | Upgrade | - |
Drug Discovery Revenue Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Drug Discovery Services Customer Contracts | 35.12M | 32.69M | 25.14M | 21.97M | 31.88M | 25.61M | 54.72M | Upgrade | Upgrade | Upgrade | Upgrade |
| Drug Discovery Services Customer Contracts Growth | +7.45% | +30.00% | +14.46% | -31.10% | +24.50% | -53.20% | -6.00% | Upgrade | Upgrade | Upgrade | - |
| Drug Discovery Contribution | 1.89M | 2.04M | 2.03M | 2.02M | 2.37M | 2.55M | 2.82M | Upgrade | Upgrade | Upgrade | Upgrade |
| Drug Discovery Contribution Growth | -7.31% | +0.39% | +0.35% | -14.45% | -7.11% | -9.74% | -2.01% | Upgrade | Upgrade | Upgrade | - |
Software Products and Services Revenue Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Software Products and Services | 27.13M | 26.27M | 23.32M | 22.81M | 23.41M | 23.37M | 22.81M | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade |
| Software Products and Services Growth | +3.26% | +12.69% | +2.20% | -2.57% | +0.18% | +2.45% | -1.38% | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | - |
| Drug Discovery | 9.03M | 7.96M | 8.98M | 8.83M | 10.88M | 11.18M | 11.1M | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade |
| Drug Discovery Growth | +13.43% | -11.41% | +1.70% | -18.83% | -2.67% | +0.74% | +31.20% | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | - |
| Software Contribution | 16.37M | 13.66M | - | - | - | - | - | - | - | - | - | - | - |
| Software Contribution Growth | +19.86% | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue by Geography
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | 124.59M | 121.23M | 114.87M | 133.14M | 141.65M | 134.91M | 161.96M | Upgrade | Upgrade | Upgrade | Upgrade |
| United States Growth | +2.76% | +5.54% | -13.73% | -6.00% | +4.99% | -16.70% | +10.82% | Upgrade | Upgrade | Upgrade | - |
| Rest of World | 1.4M | 1.34M | 1.22M | 1.16M | 1.03M | 1.07M | 1M | Upgrade | Upgrade | Upgrade | Upgrade |
| Rest of World Growth | +4.01% | +10.43% | +5.09% | +12.20% | -3.28% | +6.69% | -117.89% | Upgrade | Upgrade | Upgrade | - |
| EMEA | 80.7M | 81.54M | 65.65M | 33.86M | 32.48M | 29.5M | 29.14M | Upgrade | Upgrade | Upgrade | Upgrade |
| EMEA Growth | -1.02% | +24.20% | +93.87% | +4.27% | +10.08% | +1.26% | +5.20% | Upgrade | Upgrade | Upgrade | - |
| APAC | 31.23M | 26.38M | 25.8M | 25.18M | 25.47M | 23M | 24.57M | Upgrade | Upgrade | Upgrade | Upgrade |
| APAC Growth | +18.40% | +2.22% | +2.46% | -1.13% | +10.75% | -6.40% | -21.10% | Upgrade | Upgrade | Upgrade | - |